The recall of Jantoven® warfarin 3 mg tablets issued on February 16th has been expanded to include more dosages and additional medicines.
Jantoven and other medications that were packaged on the same Upsher-Smith Laboratories packaging line between May and November of 2010 are all being recalled as a precaution after 10 mg Jantoven tablets were found in a bottle labeled 3 mg.
Since warfarin is used to prevent blood clots in many people with cancer, it is critical that you check your medicine to be sure that it isn’t part of the Upsher-Smith recall.
A complete description of the recalled pills is available on the FDA website including the tablet color and dose. All recalled Jantoven tablets are scored and imprinted with WFR and the number 832. Read the rest of this entry »